Versnelt eiwitontwerp met machine learning en eigen natlabonderzoek
Life Sciences · Amsterdam · Opgericht 2021
Wat ze bouwen
Cradle, is a biotechnology company that develops a platform for engineering proteins used in therapeutics and industrial applications. The company's core offering is a computational platform that combines machine learning models with high-throughput wet lab experimentation to accelerate the design and optimization of proteins. This integrated approach allows researchers to generate and test protein candidates with improved properties, such as enhanced binding affinity or thermal stability, in a fraction of the time compared to traditional methods. Cradle’s platform is designed to guide the experimental process using proprietary data, enabling faster breakthroughs in areas like antibody and enzyme engineering. The company maintains its own wet lab facility to ensure the reliability and performance of its machine learning models before they are deployed to customers, offering a complete solution for protein discovery and optimization.
De mensen erachter
Wie erin gelooft
Cradle haalde in totaal €100M op. De laatste bekende ronde is Series B (2024).
Wie ermee werkt
Wat er geschreven wordt
Waar ze zitten
Omgeving laden…
Verder kijken